✦ LIBER ✦

Pharmacodynamic and pharmacokinetic profile of RBx 343E48F0: A novel, long acting muscarinic receptor antagonist

✍ Scribed by Suman Gupta; Shivani Malhotra; Sandeep Sinha; Shashi K. Singh; Rakesh K. Singh; Siddarangaiah Krishna; Pooja Chhabra; Tridib Chaira; Janaki Kannayiram; Pradeep Sharma; Shelly Aeron; Jaskiran Kaur; Naresh Kumar; Jitendra Sattigeri; Raj K. Shirumalla; Jyoti Paliwal; Sunanda G. Dastidar; Ian A. Cliffe; Abhijit Ray; Pradip Bhatnagar

Book ID: 113589248
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 549 KB
Volume: 658
Category: Article
ISSN: 0014-2999
DOI: 10.1016/j.ejphar.2011.02.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of Novel and Long Acting Musca

Discovery of Novel and Long Acting Muscarinic Acetylcholine Receptor Antagonists

✍ Jin, Jian; Wang, Yonghui; Shi, Dongchuan; Wang, Feng; Davis, Roderick S.; Jin, Q 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 355 KB

Aclidinium bromide, a novel long-acting

Aclidinium bromide, a novel long-acting muscarinic antagonist for COPD with improved preclinical renal and urinary safety profile

✍ Amadeu Gavaldà; Jordi Gras; Josep Llupià; Jordi Aubets; Jorge Beleta; Jesús Llen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 382 KB

Discovery of Biphenyl Piperazines as Nov

Discovery of Biphenyl Piperazines as Novel and Long Acting Muscarinic Acetylcholine Receptor Antagonists

✍ Jin, Jian; Budzik, Brian; Wang, Yonghui; Shi, Dongchuan; Wang, Feng; Xie, Haibo; 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 165 KB

Pharmacological, Pharmacokinetic, and Pr

Pharmacological, Pharmacokinetic, and Primate Analgesic Efficacy Profile of the Novel Bradykinin B1 Receptor Antagonist ELN441958

✍ Hawkinson, J. E.; Szoke, B. G.; Garofalo, A. W.; Hom, D. S.; Zhang, H.; Dreyer, 📂 Article 📅 2007 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 468 KB

367 Emerging pharmacokinetic (PK)-pharma

367 Emerging pharmacokinetic (PK)-pharmacodynamic (PD) profile of AEE788, a novel multi-targeted inhibitor of ErbB and VEGF receptor family tyrosine kinases

✍ J. Baselga; F. Rojo; A. van Oosterom; H. Dumez; J. Huang; E. Walk; A. Mita; E. R 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 284 KB

Pharmacokinetic and Pharmacodynamic Prop

Pharmacokinetic and Pharmacodynamic Properties of FK070 (KDI-792), A Novel Thromboxane Receptor Antagonist/Thromboxane Synthetase Inhibitor, After Single and Multiple Oral Administrations to Healthy Volunteers

✍ T. UEMATSU; K. KOSUGE; K. UMEMURA; M. NAKANO; M. TERAKAWA; M. NAKASHIMA 📂 Article 📅 1996 🏛 Pharmaceutical Press 🌐 English ⚖ 576 KB